Abstract
Background Prebiotic dietary fiber and related metabolites have been suggested to attenuate low-grade systemic and central inflammation through improving gut-brain axis signaling. We here aimed to test whether habitual or short-term high-dose fiber intake is linked to inflammatory markers in blood and to indicators of central hypothalamic inflammation.
Methods In total, 59 adults (19 women, aged 28.3 years ± 6.6 SD, mean body mass index, BMI, 27.3 ± 1.5 SD) were included into analyses. Participants completed a food frequency questionnaire, underwent diffusion-weighted magnetic resonance imaging (MRI) at 3 Tesla for provision of mean diffusivity (MD) as a marker of brain tissue inflammation and donated fasting blood. Measurements took place at up to 4 timepoints, i.e. before and after 14 days of supplementary fiber and placebo intake, respectively. High-sensitive C-reactive protein (CRP), tumor-necrosis factor alpha (TNF-α) and interleukin-6 (IL6) were assessed in serum. The study was preregistered at https://osf.io/uzbav.
Results Habitual and interventional high-fiber diet was not significantly associated with neither inflammatory markers (|ßintervention|> 0.1, p > 0.32) nor with hypothalamic MD (|ßintervention| = 1.8, p = 0.07) according to linear mixed effects modeling. Male sex and higher body fat mass related to higher CRP. Further, higher BMI was borderline related to lower hypothalamic MD.
Conclusions In this sample of overweight adults, dietary fiber intake was not related to inflammatory blood markers or hypothalamic microstructure. Instead, sex and body composition were of higher importance for prediction of interindividual differences in markers of (neuro)inflammation.
Significance Statement Prebiotic dietary fiber has been discussed to lower systemic and central inflammation. While previous studies investigated the effects of fiber on inflammatory blood markers, the knowledge of the effect of fiber on neuroinflammation is limited. Thus, in this pre-registered randomized controlled trial analysis we examined the relationship between dietary fiber intake and inflammatory markers in blood and hypothalamus. 3T MRI and blood markers were assessed before and after high-fiber intake and placebo in 59 adults. In our overweight study sample of 19-42 years old adults, fiber intake had no significant impact on inflammatory markers. The current null findings can inform future nutrition neuroimaging trials and add to the discussion about how diet may affect brain structure and function.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03829189
Funding Statement
This work was funded by grants of the German Research Foundation (DFG), contract grant number 209933838 CRC1052-03 A1 to A.V.W and M.S., and by the Berlin School of Mind and Brain (stipend for E.M.) and the German Foundation for Environment (stipend for E.M.). The inulin supplement was sponsored by the manufacturer BENEO GmbH, Mannheim, Germany.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study is part of a within-subject cross-over randomized controlled trial (RCT) investigating the effects of a prebiotic intervention on the gut-brain axis (Medawar et al., Gut, 2023). The institutional Ethics Board of the Medical Faculty of the University of Leipzig, Germany, raised no concerns regarding the study protocol (228/18-ek) and all participants provided written informed consent. Recruitment took place via the institute's database and advertisements. Remuneration was 9-10 Euro/h and an additional bonus payment of 30 Euro for completing the study. The RCT was registered at ClinicalTrials.gov (NCT03829189) and this analysis was pre-registered at https://osf.io/uzbav.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data availability Scripts for hypothalamus segmentation and extraction of MD are made available here: https://gitlab.gwdg.de/omega-lab/hypothalamus-MD.
